SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Philipp Mahlknecht, Patricia Limousin, Thomas Foltynie, Deep brain stimulation for movement disorders: update on recent discoveries and outlook on future developments, Journal of Neurology, 2015,

    CrossRef

  2. 2
    Sheida Rabipour, Patrick S.R. Davidson, Do you believe in brain training? A questionnaire about expectations of computerised cognitive training, Behavioural Brain Research, 2015,

    CrossRef

  3. 3
    Elisa Frisaldi, Elisa Carlino, Michele Lanotte, Leonardo Lopiano, Fabrizio Benedetti, Characterization of the thalamic–subthalamic circuit involved in the placebo response through single-neuron recording in Parkinson patients, Cortex, 2014, 60, 3

    CrossRef

  4. 4
    Thomas E Schlaepfer, Bettina H Bewernick, Sarah Kayser, Rene Hurlemann, Volker A Coenen, Deep Brain Stimulation of the Human Reward System for Major Depression—Rationale, Outcomes and Outlook, Neuropsychopharmacology, 2014, 39, 6, 1303

    CrossRef

  5. 5
    Johannes Levin, Arun Singh, Berend Feddersen, Jan-Hinnerk Mehrkens, Kai Bötzel, Onset latency of segmental dystonia after deep brain stimulation cessation: A randomized, double-blind crossover trial, Movement Disorders, 2014, 29, 7
  6. 6
    Tiago A. Mestre, Alberto J. Espay, Connie Marras, Mark H. Eckman, Pierre Pollak, Anthony E. Lang, Subthalamic nucleus-deep brain stimulation for early motor complications in Parkinson's disease—the EARLYSTIM trial: Early is not always better, Movement Disorders, 2014, 29, 14
  7. 7
    Karen S. Rommelfanger, Attitudes on Mind Over Matter: Physician Views on the Role of Placebo in Psychogenic Disorders, AJOB Neuroscience, 2013, 4, 3, 9

    CrossRef

  8. 8
    Jau-Shin Lou, Diana M. Dimitrova, Richard Hammerschlag, John Nutt, Elizabeth A. Hunt, Ryan W. Eaton, Sarah C. Johnson, Melanie D. Davis, Grace C. Arnold, Sarah B. Andrea, and Barry S. Oken, Effect of expectancy and personality on cortical excitability in Parkinson's disease, Movement Disorders, 2013, 28, 9
  9. 9
    Danielle Murray, A. Jon Stoessl, Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions, Pharmacology & Therapeutics, 2013, 140, 3, 306

    CrossRef

  10. 10
    Tomasz Tykocki, Pawel Nauman, Henryk Koziara, Tomasz Mandat, Microlesion Effect as a Predictor of the Effectiveness of Subthalamic Deep Brain Stimulation for Parkinson’s Disease, Stereotactic and Functional Neurosurgery, 2013, 91, 1, 12

    CrossRef

  11. 11
    Ariane Keitel, Lars Wojtecki, Jan Hirschmann, Christian J. Hartmann, Stefano Ferrea, Martin Südmeyer, Alfons Schnitzler, Motor and cognitive placebo-/nocebo-responses in Parkinson's disease patients with deep brain stimulation, Behavioural Brain Research, 2013, 250, 199

    CrossRef

  12. 12
    Paul Enck, Ulrike Bingel, Manfred Schedlowski, Winfried Rief, The placebo response in medicine: minimize, maximize or personalize?, Nature Reviews Drug Discovery, 2013, 12, 3, 191

    CrossRef

  13. 13
    Jayne Jubb, Jozien M. Bensing, The sweetest pill to swallow: How patient neurobiology can be harnessed to maximise placebo effects, Neuroscience & Biobehavioral Reviews, 2013, 37, 10, 2709

    CrossRef

  14. 14
    Hsiang-Yi Hung, Sheng-Tzung Tsai, Sheng-Huang Lin, Jiin-Ling Jiang, Shin-Yuan Chen, Uneven benefits of subthalamic nucleus deep brain stimulation in Parkinson's disease—A 7-year cross-sectional study, Tzu Chi Medical Journal, 2013, 25, 4, 239

    CrossRef

  15. 15
    Mark D. Bishop, Sergio Romero, Tara S. Patterson, Floris F. Singletary, Kathye Light, Exploration of Patient-Centered Success Criteria and Clinically Measured Improvement During Falls Rehabilitation, Journal of Geriatric Physical Therapy, 2012, 35, 4, 181

    CrossRef

  16. 16
    Rainer Schneider, Julius Kuhl, Placebo forte: Ways to maximize unspecific treatment effects, Medical Hypotheses, 2012, 78, 6, 744

    CrossRef

  17. 17
    Sergei A. Kharitonov, Religious and Spiritual Biomarkers in Both Health and Disease, Religions, 2012, 3, 4, 467

    CrossRef

  18. 18
    Anne N. Nisenzon, Michael E. Robinson, Dawn Bowers, Evangelia Banou, Irene Malaty, Michael S. Okun, Measurement of patient-centered outcomes in Parkinson’s disease: What do patients really want from their treatment?, Parkinsonism & Related Disorders, 2011, 17, 2, 89

    CrossRef

  19. 19
    C. Warren Olanow, Kathryn B. Wunderle, Karl Kieburtz, Milestones in movement disorders clinical trials: Advances and landmark studies, Movement Disorders, 2011, 26, 6
  20. 20
    Jonathan H. Dinsmore, Nabil Dib, Stem Cell Therapy for the Treatment of Acute Myocardial Infarction, Cardiology Clinics, 2010, 28, 1, 127

    CrossRef

  21. You have free access to this content21
    E Paul Cherniack, Would the elderly be better off if they were given more placebos?, Geriatrics & Gerontology International, 2010, 10, 2
  22. 22
    Paolo Gubellini, Pascal Salin, Lydia Kerkerian-Le Goff, Christelle Baunez, Deep brain stimulation in neurological diseases and experimental models: From molecule to complex behavior, Progress in Neurobiology, 2009, 89, 1, 79

    CrossRef

  23. 23
    Fabrizio Benedetti, Michele Lanotte, Luana Colloca, Alessandro Ducati, Maurizio Zibetti, Leonardo Lopiano, Electrophysiological properties of thalamic, subthalamic and nigral neurons during the anti-parkinsonian placebo response, The Journal of Physiology, 2009, 587, 15
  24. 24
    Antonella Pollo, Fabrizio Benedetti, Neurotherapy: Progress in Restorative Neuroscience and Neurology, 2009,

    CrossRef

  25. 25
    Joseph J. Fins, Neuromodulation, 2009,

    CrossRef

  26. 26
    Vanda Faria, Mats Fredrikson, Tomas Furmark, Imaging the placebo response: A neurofunctional review, European Neuropsychopharmacology, 2008, 18, 7, 473

    CrossRef

  27. 27
    Fabrizio Benedetti, Mechanisms of Placebo and Placebo-Related Effects Across Diseases and Treatments, Annual Review of Pharmacology and Toxicology, 2008, 48, 1, 33

    CrossRef

  28. 28
    Christopher G. Goetz, Joanne Wuu, Michael P. McDermott, Charles H. Adler, Stanley Fahn, Curt R. Freed, Robert A. Hauser, Warren C. Olanow, Ira Shoulson, P.K. Tandon, Sue Leurgans, Placebo response in Parkinson's disease: Comparisons among 11 trials covering medical and surgical interventions, Movement Disorders, 2008, 23, 5
  29. 29
    Jason M. Schwalb, Clement Hamani, The history and future of deep brain stimulation, Neurotherapeutics, 2008, 5, 1, 3

    CrossRef

  30. 30
    Sarah C. Christine Lidstone, A. Jon Stoessl, Understanding the Placebo Effect: Contributions from Neuroimaging, Molecular Imaging and Biology, 2007, 9, 4, 176

    CrossRef

  31. 31
    F. Benedetti, M. Lanotte, L. Lopiano, L. Colloca, When words are painful: Unraveling the mechanisms of the nocebo effect, Neuroscience, 2007, 147, 2, 260

    CrossRef